We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Can Response to Chemotherapy Be Predicted?

By LabMedica International staff writers
Posted on 01 Oct 2008
A recent publication explained why patients with the same type of cancer respond differently to identical chemotherapeutic treatments.

Investigators at the Massachusetts Institute of Technology (Cambridge, MA, USA) established tissue culture lines based on the same types of cells taken from different individuals. More...
They treated these cell lines with the carcinogenic compound MNNG and then determined the amount of genetic damage that had been caused. They reported in the September 19, 2008, online edition of Genes and Development that there was a wide range of sensitivity among cells taken from healthy people. A cell line from one person would be killed dramatically, while that from another person was resistant to exposure.

While this type of response gradient was expected, the results produced a new finding that the response rates of a group of 48 genes could be used to predict susceptibility to the drug with 94% accuracy. "Even if everyone is exposed to exactly the same things, they would respond differently, because we are all genetically different,” said senior author Dr. Leona Samson, professor of biological engineering at the Massachusetts Institute of Technology.

This study was specific to MNNG, but the investigators are working to predict individuals' responses to other toxic agents, including cisplatin, a common chemotherapy agent, and temozolomide, used to treat brain cancer.

Related Links:
Massachusetts Institute of Technology



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
POC Immunoassay Analyzer
Procise DX
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.